Ludivine DECOBERT

Ludivine Decobert has a strong background in intellectual property, with experience spanning over a decade. Ludivine is currently serving as the Head of Intellectual Property at Inventiva Pharma since May 2023. Prior to this, they worked at FIDAL INNOVATION from July 2020 to March 2023 as a Senior French & European Patent Attorney, specializing in the life sciences, biotech, and pharmaceutical industries. From September 2014 to June 2020, they worked at Ipaz as a Mandataire agréé auprès de l’OEB & Conseil en Propriété Industrielle. Before that, they were an Ingénieur Brevets at Cabinet Hirsch & Partners from August 2010 to August 2014, where they gained experience in patent drafting, prosecution, and due diligence. Ludivine started their career as an Ingénieur Brevets at LFB, where they worked from February 2009 to July 2010. Overall, Ludivine Decobert has a comprehensive knowledge of intellectual property law and experience working in various sectors.

Ludivine Decobert's education history began in 2006 when they attended Polytech Lille for a program focused on Biology and Agri-Food Industries. In 2007, they continued their studies at Polytech'Nice-Sophia, specializing in pharmacology and biotechnology, ultimately earning an engineering degree in biological sciences. From 2010 to 2011, Ludivine pursued a Diploma of Patents (D.U BREVETS) at the Center for International Intellectual Property Studies (CEIPI). In 2014, they attended OEB-EQE to become an accredited representative at the European Patent Office. In 2017, Ludivine studied at INPI-EQF, specializing in Industrial Property Consulting.